Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes. | Int J Mol Sci | 2023 | 37834388 | PubTator, text mining | PubMed |
| Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa. | Int J Mol Sci | 2023 | 37834386 | PubTator, text mining | PubMed |
| The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis. | Int J Mol Sci | 2023 | 37834346 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma. | Med Oncol | 2023 | 37831226 | PubTator, text mining | PubMed |
| [BRCA-like breast cancer patients benefit from cisplatin plus veliparib-results from the S1416 phase II study]. | Strahlenther Onkol | 2023 | 37823898 | PubTator, text mining | PubMed |
| Global analysis of suppressor mutations that rescue human genetic defects. | Genome Med | 2023 | 37821946 | PubTator, text mining | PubMed |
| Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays. | NPJ Precis Oncol | 2023 | 37821580 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Analysis of 3 Uterine Adenosarcomas with Heterogeneously Differentiated Genomic Mutations. | Int J Anal Chem | 2023 | 37810911 | PubTator, text mining | PubMed |
| Facies analysis, biostratigraphy, and provenance of the late Neogene Seulimeum Formation, Northwest Aceh basin, Sumatra (Indonesia). | Heliyon | 2023 | 37809546 | PubTator, text mining | PubMed |
| Scurvy: A treatable forgotten fatal differential diagnosis and potential etiology of leukemia and aplastic anemia in pediatric population. | Health Sci Rep | 2023 | 37808934 | PubTator, text mining | PubMed |
| [Diagnosis status and genetic characteristics analysis of Fanconi anemia in China]. | Zhonghua Er Ke Za Zhi | 2023 | 37803855 | PubTator, text mining | PubMed |
| Erratum: A self-repair history: compensatory effect of a de novo variant on the FANCA c.2778+83C>G splicing mutation. | Front Genet | 2023 | 37799138 | PubTator, text mining | PubMed |
| The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality. | Front Oncol | 2023 | 37795443 | PubTator, text mining | PubMed |
| Phenotype reversion as "natural gene therapy" in Fanconi anemia by a gene conversion event. | Front Genet | 2023 | 37790699 | PubTator, text mining | PubMed |
| Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data. | Breast Cancer (Auckl) | 2023 | 37789896 | PubTator, text mining | PubMed |
| De novo dedifferentiated SDH-deficient gastrointestinal stromal tumor with MDM2 amplification: case report and literature review. | Front Oncol | 2023 | 37781202 | PubTator, text mining | PubMed |
| Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress. | Int J Biol Sci | 2023 | 37781032 | PubTator, text mining | PubMed |
| The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers. | Asian Pac J Cancer Prev | 2023 | 37774066 | PubTator, text mining | PubMed |
| Genetic Landscape of Chronic Myeloid Leukemia and a Novel Targeted Drug for Overcoming Resistance. | Int J Mol Sci | 2023 | 37762109 | PubTator, text mining | PubMed |
| Editorial for the Special Issue "Genetics and Genomics of Gastrointestinal Cancers: From Prevention to Treatment". | Genes (Basel) | 2023 | 37761961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=17